This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of congenital toxoplasmosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Seek expert help.

  • transmission of infection from mother to fetus occurs in less than one third of cases of primary maternal infection

  • the transmission rate increases with gestational age - studies have revealed a transmission rate of 40% at 26 weeks' gestation and 72% at 36 weeks' gestation

  • the evidence relating to the use of drug therapy during pregnancy reveals no quality evidence that such interventions are beneficial

  • there is no justification for GPs in the UK to perform toxoplasmosis screening

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.